Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease.
- DOI
- 10.4103/tcmj.tcmj-d-25-00012
- Published
- 2026 Oct-Dec
- Container
- Tzu chi medical journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4103/tcmj.tcmj-d-25-00012,
title = {Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease.},
author = {Tang CC and Lin YL and Wang CH and Lai YH and Kuo CH and Hsu BG},
year = {2026},
journal = {Tzu chi medical journal},
doi = {10.4103/tcmj.tcmj-d-25-00012},
url = {https://doi.org/10.4103/tcmj.tcmj-d-25-00012}
}RIS
TY - JOUR TI - Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease. AU - Tang CC AU - Lin YL AU - Wang CH AU - Lai YH AU - Kuo CH AU - Hsu BG PY - 2026 JO - Tzu chi medical journal DO - 10.4103/tcmj.tcmj-d-25-00012 UR - https://doi.org/10.4103/tcmj.tcmj-d-25-00012 ER -
APA
CC, T., YL, L., CH, W., YH, L., CH, K., & BG, H. (2026). Serum malondialdehyde-modified low-density lipoprotein level is a risk factor for peripheral artery disease in patients with stage 3 to 5 chronic kidney disease.. Tzu chi medical journal. https://doi.org/10.4103/tcmj.tcmj-d-25-00012
Source records
- pubmed · retrieved 2026-09-26T06:37:38.138Z